Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD

NCT04560660 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT04560660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04560660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Completed
Start date
March 9, 2021
Completion date
October 7, 2025
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd